Effectiveness and safety of the oxytocin antagonist atosiban versus beta‐adrenergic agonists in the treatment of preterm labour
- 1 February 2001
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 108 (2) , 133-142
- https://doi.org/10.1111/j.1471-0528.2001.00043.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Changing prognosis for babies of less than 28 weeks' gestation in the north of England between 1983 and 1994BMJ, 1997
- Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm laborObstetrics & Gynecology, 1996
- Treatment of Preterm Labor with the Oxytocin Antagonist AtosibanAmerican Journal of Perinatology, 1996
- The effect of the oxytocin antagonists F314 and F792 on the in vitvo contractility of human myometriumBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- The effect of the oxytocin antagonist atosiban on preterm uterine activity in the humanAmerican Journal of Obstetrics and Gynecology, 1994
- Treatment of Preterm Labor with the Beta-Adrenergic Agonist RitodrineNew England Journal of Medicine, 1992
- The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trialsBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Beta‐mimetics in preterm labour: an overview of the randomized controlled trialsBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Comparative mortality and morbidity of infants transferred in utero or postnatallyjpme, 1983
- Contribution of preterm delivery to perinatal mortality.BMJ, 1976